Edward John Moler

Title: Edward John Moler: Innovator in Automated Tissue Analysis

Introduction

Edward John Moler is a notable inventor based in Aliso Viejo, CA (US). He has made significant contributions to the field of automated tissue analysis, particularly in the quality control of cell segmentation and staining processes. With a total of 2 patents, his work has the potential to enhance the accuracy and efficiency of tissue specimen evaluations.

Latest Patents

Moler's latest patents include "Automated Cell Segmentation Quality Control" and "Automated Staining and Segmentation Quality Control." The first patent focuses on an automated method for determining the segmentation quality of cells in a tissue specimen. It involves creating a training model based on expert evaluations of 'good' and 'poor' segmentation cells. This model is then used to assess the quality of cells in a test specimen, ultimately providing an overall segmentation quality score.

The second patent addresses the automated determination of staining and segmentation quality in biological specimens. This process involves acquiring separate image data of unstained specimens and those stained with specific markers. By analyzing correlation and ridgeness maps, the invention allows for the determination of staining and segmentation quality scores, enhancing the reliability of tissue analysis.

Career Highlights

Edward John Moler is currently employed at GE Healthcare Bio-Sciences Corp., where he applies his expertise in automated analysis to improve healthcare outcomes. His innovative approaches have positioned him as a key player in the field of biomedical engineering.

Collaborations

Moler has collaborated with talented individuals such as Raghav Krishna Padmanabhan and Yousef Ahmed Al-Kofahi. These collaborations have fostered a creative environment that encourages the development of cutting-edge technologies in tissue analysis.

Conclusion

Edward John Moler is a pioneering inventor whose work in automated tissue analysis is making a significant impact in the healthcare industry. His patents reflect a commitment to improving the quality and efficiency of tissue specimen evaluations. Through his contributions, he is helping to advance the field of biomedical engineering.